We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $2.58M invested in Blueprint Medicines in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 344 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less funds holding

Funds holding: 354 → 5 (-349)

99.54% less ownership

Funds ownership: 99.58% → 0.04% (-100%)

100% less capital invested

Capital invested by funds: $8.24B → $2.58M (-$8.24B)

100% less funds holding in top 10

Funds holding in top 10: 29 → 0 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 344

Holders
5
Holders Change
-349
Holders Change %
-98.59%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
344
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$822M
2
BlackRock
BlackRock
New York
-$784M
3
PCM
Pentwater Capital Management
Florida
-$500M
4
State Street
State Street
Massachusetts
-$286M
5
UBS Group
UBS Group
Switzerland
-$278M
Name Holding Trade Value Shares
Change 		Change in
Stake
GFM
276
GF Fund Management
China
– -$208K -1,626 Closed
A
277
AlphaQuest
New York
– -$208K -1,623 Closed
QCM
278
Quantinno Capital Management
New York
– -$205K -1,599 Closed
DS
279
DRW Securities
Illinois
– -$204K -1,593 Closed
BC
280
BIT Capital
Germany
– -$182K -1,423 Closed
C
281
Covestor
United Kingdom
– -$175K -1,365 Closed
Lazard Asset Management
282
Lazard Asset Management
New York
– -$172K -1,348 Closed
US Bancorp
283
US Bancorp
Minnesota
– -$154K -1,203 Closed
BC
284
Bayforest Capital
United Kingdom
– -$143K -1,112 Closed
Fifth Third Bancorp
285
Fifth Third Bancorp
Ohio
– -$128K -1,000 Closed
CI Investments Inc
286
CI Investments Inc
Ontario, Canada
– -$124K -971 Closed
EP
287
Essential Partners
California
– -$113K -878 Closed
Northwestern Mutual Wealth Management
288
Northwestern Mutual Wealth Management
Wisconsin
– -$109K -850 Closed
BNP Paribas Asset Management
289
BNP Paribas Asset Management
France
– -$75K -584 Closed
Optiver Holding
290
Optiver Holding
Netherlands
– -$52.8K -412 Closed
TIM
291
Tortoise Investment Management
New York
– -$50.9K -397 Closed
NS
292
NBC Securities
Alabama
– -$45K -355 Closed
EWA
293
EverSource Wealth Advisors
Alabama
– -$40.4K -315 Closed
DB
294
Danske Bank
Denmark
– -$38.5K -300 Closed
PA
295
Parallel Advisors
California
– -$35.3K -275 Closed
TC
296
Truvestments Capital
Florida
– -$33.3K -260 Closed
GI
297
GAMMA Investing
California
– -$32K -250 Closed
MYIA
298
Mount Yale Investment Advisors
Colorado
– -$29.6K -231 Closed
Daiwa Securities Group
299
Daiwa Securities Group
Japan
– -$29K -225 Closed
CWM
300
Crowley Wealth Management
Delaware
– -$25.6K -200 Closed
10 11
12
13 14

BPMC Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2025, worth a combined $2.58M — down 100% from $8.24B a quarter earlier.

Sellers outnumbered buyers: 344 funds closed out of BPMC and 0 opened new positions — a net loss of 344 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $2.06K. The largest seller was Vanguard Group, exiting entirely with an estimated $822M sold.

  • 5 institutional investors held Blueprint Medicines (BPMC) as of Q3 2025, down from 354 in Q2 2025.
  • Funds reported $2.58M of Blueprint Medicines stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Blueprint Medicines positions in Q3 2025 and 344 closed out, a net change of -344 holders.
  • The largest Blueprint Medicines buyer in Q3 2025 was IFP Advisors, an estimated $2.06K added.
  • The largest Blueprint Medicines seller in Q3 2025 was Vanguard Group, an estimated $822M sold.

Based on aggregated 13F filings for Q3 2025.